Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

<< Previous
Bullboard Posts
Next >>
Post by Stockfshron May 31, 2022 6:38pm
234 Views
Post# 34721595

Conformal coating questions and answers from Sernova

Conformal coating questions and answers from SernovaWow. I just received a return email from Sernova with their answers:

I have a few questions about the worldwide exclusive conformal coating commercial licensing agreement that Sernova signed with the University of Miami.
              
1) Is this agreement with the university rather than the developers such as Dr. Tomei? Or are all the parties involved to varying degrees?
               The University of Miami license agreement is with the University of Miami. The inventors including Dr. Tomei are listed as the inventors. This is standard with University license agreements.
 

2)  Being exclusive, does this mean that the university cannot sell the technology to another company that might compete with Sernova?
               Sernova owns the exclusive world wide license to the Conformal Coating technology and no one else can use it.
 
3) Is the university/Dr. Tomei still working to improve this technology? Is this for the exclusive benefit of Sernova?
 
Sernova and the University of Miami have a collaboration with Dr. Tomei’s laboratory to combine the conformal coating technologies with cells and Cell Pouch. We are working within the patent technologies and the combinations and this is for the exclusive benefit of Sernova.
 
4) Can the university through its Diabetes Research Institute (DRI) and BioHub become a commercial entity itself that could use the conformal technology and/or their other developing technologies to compete directly with Sernova?
               No, they do not have rights to use the technologies we have licensed for commercial purposes.
<< Previous
Bullboard Posts
Next >>